Thu, Nov 12, 2026 - Page 23
13819 indexed SquawkNews stories from this UTC day. Showing 2641-2760.
L
BIRCHTECH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
BIRCHTECH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
PARK DENTAL PARTNERS INC Q3 EPS USD 0.27
PARK DENTAL PARTNERS INC Q3 EPS USD 0.27
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
PARK DENTAL PARTNERS INC Q3 ADJUSTED EBITDA USD 5 MILLION
PARK DENTAL PARTNERS INC Q3 ADJUSTED EBITDA USD 5 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
NEEDHAM, Mass., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) NASDAQ:CADL, a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outc
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
FORTIFY, a Phase 1b indication expansion trial of PLN-101095, continues strong enrollmentPliant’s proprietary selective, targeted, integrin-mediated delivery platformdemonstrates encouraging initial preclinical resultsSt
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
Digital Realty’s board authorized fourth-quarter 2026 cash dividends for common and preferred stock.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
TOMI ENVIRONMENTAL SOLUTIONS, INC Q3 GROSS MARGIN 59%
TOMI ENVIRONMENTAL SOLUTIONS, INC Q3 GROSS MARGIN 59%
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Azora Therapeutics Reports 2026 Third Quarter Financial Results and Provides Business Update
Azora Therapeutics commenced trading on Nasdaq as “AZR”New executive team and Board of Directors appointedAT177 IND submission and Phase 1a initiation on track for the first half of 2027LOS ANGELES, Nov. 12, 2026 (GLOBE
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
ALUMIS Q3 NET INCOME USD -94.881 MILLION
ALUMIS Q3 NET INCOME USD -94.881 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
VIRTRA Q3 NET INCOME USD 2.2 MILLION
VIRTRA Q3 NET INCOME USD 2.2 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
LIFEMD INC Q3 REVENUE USD 44.6 MILLION VS. IBES ESTIMATE USD 48.9 MILLION
LIFEMD INC Q3 REVENUE USD 44.6 MILLION VS. IBES ESTIMATE USD 48.9 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Fluent Announces Third Quarter 2026 Financial Results; Commerce Media Solutions Revenue Doubles and Annual Run Rate Now Exceeds $145 Million
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Fluent, Inc. NASDAQ:FLNT (the “Company” or “Fluent”), a commerce media solutions provider, today reported unaudited financial results for the third quarter ended September 30,
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS Q2 PRETAX PROFIT USD 1.786 MILLION
CROWN CRAFTS Q2 PRETAX PROFIT USD 1.786 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
WIDEPOINT CORP Q3 GROSS PROFIT USD 6.2 MILLION
WIDEPOINT CORP Q3 GROSS PROFIT USD 6.2 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLUENT Q3 ADJUSTED EBITDA USD 0 VS. IBES ESTIMATE USD -518.8 THOUSAND
FLUENT Q3 ADJUSTED EBITDA USD 0 VS. IBES ESTIMATE USD -518.8 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
Solésence Reports Record Third Quarter 2026 Financial Results
Third quarter revenue increases 38% year-over-year to $20.2 millionThird quarter net income of $3.7 million highest in company’s historyCompany to host conference call today at 4:00 p.m. CT, 5:00 p.m. ETROMEOVILLE, Ill.,
CRYPTO | Nov 12, 2026, 09:06 PM UTC
L
PARK DENTAL PARTNERS INC Q3 REVENUE USD 64.9 MILLION
PARK DENTAL PARTNERS INC Q3 REVENUE USD 64.9 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS Q2 OPERATING INCOME USD 1.564 MILLION
CROWN CRAFTS Q2 OPERATING INCOME USD 1.564 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Dyadic Announces Third Quarter 2026 Financial Results and Recent Developments
Advances Commercialization, Expands Strategic Partnerships and Accelerates Biopharmaceutical Platfor
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
CANDEL THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
CANDEL THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT CORPORATE HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
TOMI ENVIRONMENTAL SOLUTIONS, INC. REPORTS PRELIMINARY THIRD QUARTER 2026 FINANCIAL RESULTS
TOMI ENVIRONMENTAL SOLUTIONS, INC. REPORTS PRELIMINARY THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
4DMT REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS, OPERATIONAL HIGHLIGHTS AND EXPECTED UPCOMING MILESTONES
4DMT REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS, OPERATIONAL HIGHLIGHTS AND EXPECTED UPCOMING MILE
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Birchtech Reports Third Quarter 2026 Financial Results
Birchtech Reports Third Quarter 2026 Financial Results Third Quarter 2026 Product Revenues Grew 15.7
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
U.S. GLOBAL INVESTORS REPORTS 18% REVENUE GROWTH AND RETURNS TO OPERATING PROFITABILITY IN FIRST QUARTER OF FISCAL 2027
U.S. GLOBAL INVESTORS REPORTS 18% REVENUE GROWTH AND RETURNS TO OPERATING PROFITABILITY IN FIRST QUA
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
New Phase 3 data demonstrated rapid and durable improvements in plaque psoriasis burden, adding to envudeucitinib's differentiated clinical profile, including the highest publicly reported Week 48 PASI 100 response rate
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SPERO THERAPEUTICS ANNOUNCES THIRD QUARTER 2026 OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
SPERO THERAPEUTICS ANNOUNCES THIRD QUARTER 2026 OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Dyadic Announces Third Quarter 2026 Financial Results and Recent Developments
Dyadic Announces Third Quarter 2026 Financial Results and Recent Developments Advances Commercializa
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
WIDEPOINT CORP Q3 REVENUE USD 45.1 MILLION
WIDEPOINT CORP Q3 REVENUE USD 45.1 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
PLIANT THERAPEUTICS PROVIDES CORPORATE UPDATE AND REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
AMPLITECH GROUP INC. Q3 GROSS PROFIT USD 2.25 MILLION
AMPLITECH GROUP INC. Q3 GROSS PROFIT USD 2.25 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
VIRTRA REPORTS THIRD QUARTER AND NINE MONTHS 2026 FINANCIAL RESULTS
VIRTRA REPORTS THIRD QUARTER AND NINE MONTHS 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
OpenWorld, Inc. Reports 2026 Third Quarter Results; First Quarterly Results as a Nasdaq-Listed Company
LAKE MARY, Fla., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Real-world assets (“RWA”) revenue increased to ap
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Lineage Cell Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Acquired NeuroAirmid Therapeutics, Inc. and Its Cell Therapy Product Candidate for Huntington’s Dise
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SOUNDTHINKING Q3 NET INCOME USD -8.472 MILLION
SOUNDTHINKING Q3 NET INCOME USD -8.472 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Beeline Q3 2026 Revenue Increases 30% Year-Over-Year; Net Loss Decreases 6% and Adjusted EBITDA Loss Narrows 33% Sequentially
Beeline Q3 2026 Revenue Increases 30% Year-Over-Year; Net Loss Decreases 6% and Adjusted EBITDA Loss
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
4D MOLECULAR THERAPEUTICS Q3 OPERATING INCOME USD -81.218 MILLION VS. IBES ESTIMATE USD -79 MILLION
4D MOLECULAR THERAPEUTICS Q3 OPERATING INCOME USD -81.218 MILLION VS. IBES ESTIMATE USD -79 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
MERLIN INC Q3 INCOME FROM OPERATIONS USD -31.473 MILLION
MERLIN INC Q3 INCOME FROM OPERATIONS USD -31.473 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Dillard’s, Inc. Reports Third Quarter and Year-to-Date Results
Dillard’s, Inc. Reports Third Quarter and Year-to-Date Results LITTLE ROCK, Ark., Nov.
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
RELMADA THERAPEUTICS Q3 NET INCOME USD -13.9 MILLION
RELMADA THERAPEUTICS Q3 NET INCOME USD -13.9 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
WIDEPOINT CORP Q3 ADJUSTED EBITDA USD 340 THOUSAND
WIDEPOINT CORP Q3 ADJUSTED EBITDA USD 340 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
FRACTYL HEALTH Q3 NET INCOME USD -14.2 MILLION
FRACTYL HEALTH Q3 NET INCOME USD -14.2 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS Q2 BASIC EPS USD 0.12
CROWN CRAFTS Q2 BASIC EPS USD 0.12
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates REMAIN-1 Pivotal Co
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
STREAMEX REPORTS THIRD QUARTER 2026 RESULTS
STREAMEX REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Newsmax Announces Third Quarter 2026 Financial Results
Newsmax Announces Third Quarter 2026 Financial Results BOCA RATON, FL / ACCESS Newswire / November 1
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Snail, Inc. Reports Third Quarter 2026 Financial Results
CULVER CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Snail, Inc.
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027
SAN ANTONIO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- U.S.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
PARK DENTAL PARTNERS INC Q3 ADJUSTED EBITDA MARGIN 7.7%
PARK DENTAL PARTNERS INC Q3 ADJUSTED EBITDA MARGIN 7.7%
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
FLUENT Q3 ADJUSTED NET INCOME USD -2.5 MILLION VS. IBES ESTIMATE USD -4.91 MILLION
FLUENT Q3 ADJUSTED NET INCOME USD -2.5 MILLION VS. IBES ESTIMATE USD -4.91 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
4D MOLECULAR THERAPEUTICS Q3 BASIC EPS USD -1.08
4D MOLECULAR THERAPEUTICS Q3 BASIC EPS USD -1.08
EARNINGS | Nov 12, 2026, 09:06 PM UTC
H
NeuroPace Reports Third Quarter 2026 Financial Results and Provides Revised Full Year Guidance
-Q3 2026 total revenue of $23.1 million, including $22.9 million in RNS revenue representing 1% gro
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLUENT Q3 EPS USD -0.1
FLUENT Q3 EPS USD -0.1
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS Q2 REVENUE USD 19.028 MILLION
CROWN CRAFTS Q2 REVENUE USD 19.028 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
RELMADA THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
RELMADA THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
4DMT Reports Third Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
4DMT Reports Third Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Mile
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
DYADIC ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT DEVELOPMENTS
DYADIC ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT DEVELOPMENTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
M
Cisco Reports Q1 Net Income of $4.6 Billion
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
WidePoint Reports Third Quarter 2026 Financial Results
WidePoint Reports Third Quarter 2026 Financial Results FAIRFAX, Va., Nov. 12, 2026 (GLOBE NEWSWIRE)
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SYSTEM1 INC. Q3 REVENUE USD 26 MILLION
SYSTEM1 INC. Q3 REVENUE USD 26 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results FORTI
EQUITY | Nov 12, 2026, 09:06 PM UTC
H
Applied Materials earnings above expectations at 4.16 USD
Applied Materials (AMAT) released earnings per share at 4.16 USD, compared to market expectations of 4.06 USD.
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
INTELLICHECK Q3 NET INCOME USD 471 THOUSAND
INTELLICHECK Q3 NET INCOME USD 471 THOUSAND
FX | Nov 12, 2026, 09:06 PM UTC
L
PLIANT THERAPEUTICS Q3 NET INCOME USD -24.377 MILLION
PLIANT THERAPEUTICS Q3 NET INCOME USD -24.377 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
BIOSTEM TECHNOLOGIES, INC. Q3 REVENUE USD 6.8 MILLION
BIOSTEM TECHNOLOGIES, INC. Q3 REVENUE USD 6.8 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights The
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES REPORTS PRELIMINARY THIRD QUARTER 2026 FINANCIAL RESULTS
TRANSACT TECHNOLOGIES REPORTS PRELIMINARY THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
ALUMIS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS UPDATES
ALUMIS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS RECENT BUSINESS UPDATES
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BIOSTEM TECHNOLOGIES, INC. Q3 NET INCOME USD -11.4 MILLION
BIOSTEM TECHNOLOGIES, INC. Q3 NET INCOME USD -11.4 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
AMPLITECH GROUP REPORTS Q3 2026 REVENUE OF $6.58 MILLION, UP 8.0% YEAR-OVER-YEAR, AND 41.1% NINE-MONTH GROSS PROFIT GROWTH
AMPLITECH GROUP REPORTS Q3 2026 REVENUE OF $6.58 MILLION, UP 8.0% YEAR-OVER-YEAR, AND 41.1% NINE-MON
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS Q2 GROSS PROFIT USD 6.083 MILLION
CROWN CRAFTS Q2 GROSS PROFIT USD 6.083 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Crown Crafts Announces Financial Results for Second Quarter Fiscal 2027
Crown Crafts Announces Financial Results for Second Quarter Fiscal 2027 GONZALES, La., Nov. 12, 2026
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SPERO THERAPEUTICS Q3 NET INCOME USD -44.278 MILLION
SPERO THERAPEUTICS Q3 NET INCOME USD -44.278 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Rank One Computing 3Q EPS 3c >ROC
Rank One Computing 3Q EPS 3c >ROC
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
AVAX ONE TECHNOLOGY LTD Q3 OPERATING INCOME USD 52.427 MILLION
AVAX ONE TECHNOLOGY LTD Q3 OPERATING INCOME USD 52.427 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
INNOVATE CORP. ANNOUNCES THIRD QUARTER 2026 RESULTS
INNOVATE CORP. ANNOUNCES THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
PARK DENTAL PARTNERS INC Q3 NET INCOME USD 1.7 MILLION
PARK DENTAL PARTNERS INC Q3 NET INCOME USD 1.7 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieves Quarterly Profitability
ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieve
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Virgin Galactic Announces Third Quarter 2026 Financial Results and Provides Business Update
First Glide Flight with Lead Spaceship, Apeiron, Expected in January, and First Commercial Spaceflig
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
AMPLITECH GROUP INC. Q3 GROSS MARGIN 34.2%
AMPLITECH GROUP INC. Q3 GROSS MARGIN 34.2%
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
PRF Technologies Requests Hearing After Nasdaq Delisting Determination
Nasdaq issued a delisting determination concerning PRF Technologies’ minimum bid price requirement, and the company requested a hearing.
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BOLT BIOTHERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
BOLT BIOTHERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
IMMUCELL CORPORATION Q3 PRODUCT SALES USD 8.04 MILLION
IMMUCELL CORPORATION Q3 PRODUCT SALES USD 8.04 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
INTELLICHECK Q3 GROSS PROFIT USD 5.217 MILLION
INTELLICHECK Q3 GROSS PROFIT USD 5.217 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SNAIL, INC. REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
SNAIL, INC. REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Codexis Reports Third Quarter 2026 Financial Results and Provides Business Update
Reports revenue of $19.3 million for the third quarter of 2026, company reiterates full-year revenue
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Financial Results
TOMI Environmental Solutions, Inc. Reports Preliminary Third Quarter 2026 Financial Results FREDERIC
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
BEELINE Q3 2026 REVENUE INCREASES 30% YEAR-OVER-YEAR; NET LOSS DECREASES 6% AND ADJUSTED EBITDA LOSS NARROWS 33% SEQUENTIALLY
BEELINE Q3 2026 REVENUE INCREASES 30% YEAR-OVER-YEAR; NET LOSS DECREASES 6% AND ADJUSTED EBITDA LOSS
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
PARK DENTAL PARTNERS ANNOUNCES THIRD QUARTER 2026 RESULTS
PARK DENTAL PARTNERS ANNOUNCES THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
FLOWERS FOODS Q3 EPS USD 0.07
FLOWERS FOODS Q3 EPS USD 0.07
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SOLESENCE INC Q3 GROSS PROFIT USD 7.928 MILLION
SOLESENCE INC Q3 GROSS PROFIT USD 7.928 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
Sensus Healthcare Reports Third Quarter 2026 Financial Results and Business Highlights
Commercial Momentum Builds with Broader Physician Engagement and Customer Adoption New Dermatology G
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Merlin 3Q EPS 37c >MRLN
Merlin 3Q EPS 37c >MRLN
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SHIMMICK CORPORATION ANNOUNCES THIRD QUARTER 2026 RESULTS
SHIMMICK CORPORATION ANNOUNCES THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SoundThinking, Inc. Reports Third Quarter 2026 Financial Results
SoundThinking, Inc. Reports Third Quarter 2026 Financial Results FREMONT, Calif., Nov.
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SOLÉSENCE REPORTS RECORD THIRD QUARTER 2026 FINANCIAL RESULTS
SOLÉSENCE REPORTS RECORD THIRD QUARTER 2026 FINANCIAL RESULTS
CRYPTO | Nov 12, 2026, 09:06 PM UTC
L
SOUNDTHINKING Q3 REVENUE USD 25.01 MILLION VS. IBES ESTIMATE USD 25 MILLION
SOUNDTHINKING Q3 REVENUE USD 25.01 MILLION VS. IBES ESTIMATE USD 25 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
FLUENT Q3 ADJUSTED EPS USD -0.08 VS. IBES ESTIMATE USD -0.14
FLUENT Q3 ADJUSTED EPS USD -0.08 VS. IBES ESTIMATE USD -0.14
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
TRANSACT TECHNOLOGIES OUTLOOK FY ADJUSTED EBITDA USD 1.5-1.75 MILLION
TRANSACT TECHNOLOGIES OUTLOOK FY ADJUSTED EBITDA USD 1.5-1.75 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
NEUROPACE, INC. Q3 NET INCOME USD -3.298 MILLION
NEUROPACE, INC. Q3 NET INCOME USD -3.298 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Enhanced Group Inc. Reports Third Quarter 2026 Results
Definitive agreement signed to acquire ~77% of DEAG Deutsche Entertainment AG as announced on Novemb
MNA | Nov 12, 2026, 09:06 PM UTC
L
FLOWERS FOODS Q3 ADJUSTED EPS USD 0.1 VS. IBES ESTIMATE USD 0.15
FLOWERS FOODS Q3 ADJUSTED EPS USD 0.1 VS. IBES ESTIMATE USD 0.15
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
AKARI THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS CONTINUED PROGRESS TOWARD CLINICAL DEVELOPMENT OF DIFFERENTIA
AKARI THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS CONTINUED PROGRESS TO
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
REKOR SYSTEMS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
REKOR SYSTEMS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
SELLAS LIFE SCIENCES Q3 OPERATING INCOME USD -11.309 MILLION
SELLAS LIFE SCIENCES Q3 OPERATING INCOME USD -11.309 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates
Alumis Reports Third Quarter 2026 Financial Results and Highlights Recent Business Updates — New Pha
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
ADARx Reports Third Quarter 2026 Financial Results and Provides Business Updates
Completed initial public offering (IPO) and concurrent private placement generating aggregate gros
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
WIDEPOINT REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
WIDEPOINT REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
DIGIMARC Q3 GROSS PROFIT USD 3.525 MILLION
DIGIMARC Q3 GROSS PROFIT USD 3.525 MILLION
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
ROC DELIVERS RECORD QUARTERLY REVENUE OF $8.0 MILLION IN THE THIRD-QUARTER 2026, UP 50% YOY; ACHIEVES QUARTERLY PROFITABILITY
ROC DELIVERS RECORD QUARTERLY REVENUE OF $8.0 MILLION IN THE THIRD-QUARTER 2026, UP 50% YOY; ACHIEVE
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
SOLESENCE INC Q3 ADJUSTED EBITDA USD 4.308 MILLION
SOLESENCE INC Q3 ADJUSTED EBITDA USD 4.308 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS Q2 NET INCOME USD 1.317 MILLION
CROWN CRAFTS Q2 NET INCOME USD 1.317 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
CROWN CRAFTS ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL 2027
CROWN CRAFTS ANNOUNCES FINANCIAL RESULTS FOR SECOND QUARTER FISCAL 2027
EQUITY | Nov 12, 2026, 09:06 PM UTC
H
NorthStar Earth & Space Enterprises, Inc. (NSTR) Q3 Revenue Rises to $17.2M
Q3 2026 revenue was $17.2M versus $1.4M in Q3 2025; net income was $7.7M versus a $6.2M loss. NorthStar reiterated 2026 revenue guidance of $41M, compared with $10.6M in 2025.Material DetailsContext by AI AnalystThis is
EARNINGS | Nov 12, 2026, 09:06 PM UTC
L
AVAX One Reports Third Quarter 2026 Financial and Operating Results
AVAX One Reports Third Quarter 2026 Financial and Operating Results Reaffirms Focus on Avalanche Dig
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
EQUILLIUM REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT CORPORATE AND CLINICAL HIGHLIGHTS
EQUILLIUM REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT CORPORATE AND CLINICAL HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Bolt Biotherapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Completed acquisition of Prana Therapies and $120 million concurrent private placement financing, es
MNA | Nov 12, 2026, 09:06 PM UTC
L
SHIMMICK CORP Q3 ADJUSTED EBITDA USD 9 MILLION
SHIMMICK CORP Q3 ADJUSTED EBITDA USD 9 MILLION
FX | Nov 12, 2026, 09:06 PM UTC
L
SENSUS HEALTHCARE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
SENSUS HEALTHCARE REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
Digimarc Reports Third Quarter 2026 Financial Results
Narrowing our Aperture to Accelerate BEAVERTON, Ore.--(BUSINESS WIRE)-- Digimarc Corporation (NASDAQ
EQUITY | Nov 12, 2026, 09:06 PM UTC
L
ADARX REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
ADARX REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
EQUITY | Nov 12, 2026, 09:06 PM UTC